These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

670 related items for PubMed ID: 18341428

  • 1. Cerebral amyloid-beta protein accumulation with aging in cotton-top tamarins: a model of early Alzheimer's disease?
    Lemere CA, Oh J, Stanish HA, Peng Y, Pepivani I, Fagan AM, Yamaguchi H, Westmoreland SV, Mansfield KG.
    Rejuvenation Res; 2008 Apr; 11(2):321-32. PubMed ID: 18341428
    [Abstract] [Full Text] [Related]

  • 2. Alzheimer's disease.
    De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV.
    Subcell Biochem; 2012 Apr; 65():329-52. PubMed ID: 23225010
    [Abstract] [Full Text] [Related]

  • 3. Cerebral amyloid β(42) deposits and microvascular pathology in ageing baboons.
    Ndung'u M, Härtig W, Wegner F, Mwenda JM, Low RW, Akinyemi RO, Kalaria RN.
    Neuropathol Appl Neurobiol; 2012 Aug; 38(5):487-99. PubMed ID: 22126319
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.
    Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, Sue L, Beach T, Kurth JH, Rydel RE, Rogers J.
    Am J Pathol; 1999 Sep; 155(3):853-62. PubMed ID: 10487842
    [Abstract] [Full Text] [Related]

  • 6. Aging, cortical injury and Alzheimer's disease-like pathology in the guinea pig brain.
    Bates K, Vink R, Martins R, Harvey A.
    Neurobiol Aging; 2014 Jun; 35(6):1345-51. PubMed ID: 24360504
    [Abstract] [Full Text] [Related]

  • 7. Characteristics of aquaporin expression surrounding senile plaques and cerebral amyloid angiopathy in Alzheimer disease.
    Hoshi A, Yamamoto T, Shimizu K, Ugawa Y, Nishizawa M, Takahashi H, Kakita A.
    J Neuropathol Exp Neurol; 2012 Aug; 71(8):750-9. PubMed ID: 22805778
    [Abstract] [Full Text] [Related]

  • 8. Active full-length DNA Aβ42 immunization in 3xTg-AD mice reduces not only amyloid deposition but also tau pathology.
    Rosenberg RN, Fu M, Lambracht-Washington D.
    Alzheimers Res Ther; 2018 Nov 20; 10(1):115. PubMed ID: 30454039
    [Abstract] [Full Text] [Related]

  • 9. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD.
    Int Rev Neurobiol; 2012 Nov 20; 102():277-316. PubMed ID: 22748834
    [Abstract] [Full Text] [Related]

  • 10. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
    Bi Oh S, Suh N, Kim I, Lee JY.
    Brain Res; 2015 Feb 09; 1597():159-67. PubMed ID: 25454795
    [Abstract] [Full Text] [Related]

  • 11. Alzheimer's Disease Neuropathological Change in Aged Non-Primate Mammals.
    Ferrer I.
    Int J Mol Sci; 2024 Jul 25; 25(15):. PubMed ID: 39125687
    [Abstract] [Full Text] [Related]

  • 12. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
    Browne TC, McQuillan K, McManus RM, O'Reilly JA, Mills KH, Lynch MA.
    J Immunol; 2013 Mar 01; 190(5):2241-51. PubMed ID: 23365075
    [Abstract] [Full Text] [Related]

  • 13. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A, Döbeli H, Bohrmann B.
    Neuroscience; 2006 Dec 01; 143(2):461-75. PubMed ID: 17008022
    [Abstract] [Full Text] [Related]

  • 14. Reduction of Abeta accumulation in the Tg2576 animal model of Alzheimer's disease after oral administration of the phosphatidyl-inositol kinase inhibitor wortmannin.
    Haugabook SJ, Le T, Yager D, Zenk B, Healy BM, Eckman EA, Prada C, Younkin L, Murphy P, Pinnix I, Onstead L, Sambamurti K, Golde TE, Dickson D, Younkin SG, Eckman CB.
    FASEB J; 2001 Jan 01; 15(1):16-18. PubMed ID: 11099491
    [Abstract] [Full Text] [Related]

  • 15. Detection of amyloid plaques by radioligands for Abeta40 and Abeta42: potential imaging agents in Alzheimer's patients.
    Kung MP, Skovronsky DM, Hou C, Zhuang ZP, Gur TL, Zhang B, Trojanowski JQ, Lee VM, Kung HF.
    J Mol Neurosci; 2003 Feb 01; 20(1):15-24. PubMed ID: 12663930
    [Abstract] [Full Text] [Related]

  • 16. Aged chimpanzees exhibit pathologic hallmarks of Alzheimer's disease.
    Edler MK, Sherwood CC, Meindl RS, Hopkins WD, Ely JJ, Erwin JM, Mufson EJ, Hof PR, Raghanti MA.
    Neurobiol Aging; 2017 Nov 01; 59():107-120. PubMed ID: 28888720
    [Abstract] [Full Text] [Related]

  • 17. Accumulation of cellular prion protein within dystrophic neurites of amyloid plaques in the Alzheimer's disease brain.
    Takahashi RH, Tobiume M, Sato Y, Sata T, Gouras GK, Takahashi H.
    Neuropathology; 2011 Jun 01; 31(3):208-14. PubMed ID: 21062360
    [Abstract] [Full Text] [Related]

  • 18. Inflammation occurs early during the Abeta deposition process in TgCRND8 mice.
    Dudal S, Krzywkowski P, Paquette J, Morissette C, Lacombe D, Tremblay P, Gervais F.
    Neurobiol Aging; 2004 Aug 01; 25(7):861-71. PubMed ID: 15212840
    [Abstract] [Full Text] [Related]

  • 19. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.
    Lemere CA, Blusztajn JK, Yamaguchi H, Wisniewski T, Saido TC, Selkoe DJ.
    Neurobiol Dis; 1996 Feb 01; 3(1):16-32. PubMed ID: 9173910
    [Abstract] [Full Text] [Related]

  • 20. β-Secretase-1 elevation in aged monkey and Alzheimer's disease human cerebral cortex occurs around the vasculature in partnership with multisystem axon terminal pathogenesis and β-amyloid accumulation.
    Cai Y, Xiong K, Zhang XM, Cai H, Luo XG, Feng JC, Clough RW, Struble RG, Patrylo PR, Chu Y, Kordower JH, Yan XX.
    Eur J Neurosci; 2010 Oct 01; 32(7):1223-38. PubMed ID: 20726888
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.